SI0788509T1 - Therapeutic peptide derivatives - Google Patents
Therapeutic peptide derivativesInfo
- Publication number
- SI0788509T1 SI0788509T1 SI9430451T SI9430451T SI0788509T1 SI 0788509 T1 SI0788509 T1 SI 0788509T1 SI 9430451 T SI9430451 T SI 9430451T SI 9430451 T SI9430451 T SI 9430451T SI 0788509 T1 SI0788509 T1 SI 0788509T1
- Authority
- SI
- Slovenia
- Prior art keywords
- peptide derivatives
- therapeutic peptide
- peptide
- amino
- amide
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
- C07K7/086—Bombesin; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
- A61P5/04—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin for decreasing, blocking or antagonising the activity of the hypothalamic hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
- A61P5/08—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH for decreasing, blocking or antagonising the activity of the anterior pituitary hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/655—Somatostatins
- C07K14/6555—Somatostatins at least 1 amino acid in D-form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10419493A | 1993-08-09 | 1993-08-09 | |
PCT/US1994/008875 WO1995004752A1 (en) | 1993-08-09 | 1994-08-08 | Therapeutic peptide derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
SI0788509T1 true SI0788509T1 (en) | 2003-10-31 |
Family
ID=22299154
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SI9420051A SI9420051A (en) | 1993-08-09 | 1994-08-08 | Chemical modified peptide derivatives, process for their preparation and their use in human therapy |
SI9430451T SI0788509T1 (en) | 1993-08-09 | 1994-08-08 | Therapeutic peptide derivatives |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SI9420051A SI9420051A (en) | 1993-08-09 | 1994-08-08 | Chemical modified peptide derivatives, process for their preparation and their use in human therapy |
Country Status (30)
Country | Link |
---|---|
US (1) | US5552520A (zh) |
EP (3) | EP1288223B1 (zh) |
JP (3) | JP3618750B2 (zh) |
KR (1) | KR100325972B1 (zh) |
CN (1) | CN1055700C (zh) |
AT (3) | ATE284413T1 (zh) |
AU (1) | AU689490B2 (zh) |
CA (1) | CA2168113C (zh) |
CZ (3) | CZ292586B6 (zh) |
DE (3) | DE69432758T2 (zh) |
DK (3) | DK1288223T3 (zh) |
ES (3) | ES2309131T3 (zh) |
FI (1) | FI960584A0 (zh) |
GE (1) | GEP20002146B (zh) |
HK (2) | HK1053313A1 (zh) |
HU (1) | HU224350B1 (zh) |
LT (1) | LT4078B (zh) |
LV (1) | LV11549B (zh) |
MD (1) | MD1591B2 (zh) |
NZ (1) | NZ271238A (zh) |
PL (1) | PL180612B1 (zh) |
PT (2) | PT1288223E (zh) |
RO (1) | RO117259B1 (zh) |
RU (1) | RU2133252C1 (zh) |
SG (1) | SG75092A1 (zh) |
SI (2) | SI9420051A (zh) |
SK (1) | SK15096A3 (zh) |
UA (1) | UA44707C2 (zh) |
WO (1) | WO1995004752A1 (zh) |
ZA (1) | ZA945966B (zh) |
Families Citing this family (61)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2774769B2 (ja) * | 1993-04-26 | 1998-07-09 | 賢治 寒川 | アドレノメデュリン |
JP3821485B2 (ja) * | 1995-03-20 | 2006-09-13 | 協和醗酵工業株式会社 | 新規カルシトニン誘導体 |
US5824772A (en) * | 1995-04-04 | 1998-10-20 | Advanced Bioconcept, Inc. | Fluorescent somatostatin |
US6861053B1 (en) | 1999-08-11 | 2005-03-01 | Cedars-Sinai Medical Center | Methods of diagnosing or treating irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth |
US7048906B2 (en) | 1995-05-17 | 2006-05-23 | Cedars-Sinai Medical Center | Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions |
US6479457B2 (en) * | 1995-06-06 | 2002-11-12 | Kinerton Limited | Ionic molecular conjugates of N-acylated derivatives of poly(2-amino-2-deoxy-D-glucose) and polypeptides |
US5830431A (en) * | 1995-06-07 | 1998-11-03 | Mallinckrodt Medical, Inc. | Radiolabeled peptide compositions for site-specific targeting |
US6544949B1 (en) | 1995-07-13 | 2003-04-08 | Societe De Conseils De Recherches Et D'applications Scientifiques, S.A.S. | Analogs of parathyroid hormone |
US7410948B2 (en) | 1995-07-13 | 2008-08-12 | Societe De Conseils De Recherches Et D'applications Scientifiques, Sas | Analogs of parathyroid hormone |
US5766620A (en) * | 1995-10-23 | 1998-06-16 | Theratech, Inc. | Buccal delivery of glucagon-like insulinotropic peptides |
US7078413B2 (en) | 1996-04-19 | 2006-07-18 | Wisconsin Alumni Research Foundation | Compositions and methods of use for a bombesin peptide |
US6492330B1 (en) * | 1996-08-16 | 2002-12-10 | National Institute Of Immunology | Antiangiogenic drugs |
US5968903A (en) * | 1998-05-07 | 1999-10-19 | Biomeasure, Incorporated | Inhibition of H. pylori proliferation |
US6124263A (en) * | 1998-11-16 | 2000-09-26 | Asta Medica Ag | Treatment of tumors by administration of growth hormone releasing compounds and their antagonists |
US6864234B1 (en) | 1999-06-25 | 2005-03-08 | Societe De Conseils De Recherches Et D'applications Scientifiques, S.A.S. | Somatostatin agonists |
EP1189942A1 (en) * | 1999-06-25 | 2002-03-27 | Societe De Conseils De Recherches Et D'applications Scientifiques S.A. (S.C.R.A.S.) | Somatostatin agonists |
US7109166B1 (en) | 1999-08-18 | 2006-09-19 | Societe De Conseils De Recherches Et D'applications Scientifiques, Sas | Sustained release formulation of a peptide |
EP1348444B1 (en) * | 1999-08-18 | 2006-04-12 | Societe De Conseils De Recherches Et D'applications Scientifiques S.A.S. | Sustained release formulation of a peptide complexed with a polymer |
AU2004200688B2 (en) * | 1999-08-18 | 2007-01-25 | Ipsen Pharma S.A.S. | Sustained release formulation of a peptide |
IES990700A2 (en) * | 1999-08-18 | 2001-08-22 | Kinerton Ltd | Process to make a sustained release formulation |
KR20020031407A (ko) * | 1999-08-18 | 2002-05-01 | 다푸르 가브리에 | 펩타이드의 서방형 제제 |
GB0018891D0 (en) | 2000-08-01 | 2000-09-20 | Novartis Ag | Organic compounds |
US6316414B1 (en) | 2000-07-31 | 2001-11-13 | Dabur Research Foundation | Somatostatin analogs for the treatment of cancer |
MD2074G2 (ro) * | 2000-12-29 | 2003-06-30 | Юрий НИКИТИН | Procedeu şi instalaţie de captare a vaporilor de carburant la staţiile de alimentare cu petrol, condensator al vaporilor de carburant utilizat în instalaţia menţionată |
ATE430162T1 (de) | 2001-03-06 | 2009-05-15 | Il Consorzio Ferrara Richerche | Verfahren zur modulation der proliferation von schilddrüsenkrebszellen |
CZ299362B6 (cs) * | 2001-03-08 | 2008-07-02 | The Administrators Of The Tulane Educational Fund | Antagonisté somatostatinu |
US20030229013A1 (en) * | 2001-12-07 | 2003-12-11 | Shih-Kwang Wu | Solid phase method for synthesis peptide-spacer-lipid conjugates, conjugates synthesized thereby and targeted liposomes containing the same |
FR2833596B1 (fr) * | 2001-12-14 | 2005-02-18 | Aventis Pharma Sa | Procede de preparation de derives d'echinocandine |
US20040171070A1 (en) * | 2002-05-20 | 2004-09-02 | Ramagauri Bhikhabhai | Peptide analysis using a solid support |
CA2510199A1 (en) | 2002-12-17 | 2004-07-08 | Nastech Pharmaceutical Company Inc. | Compositions and methods for enhanced mucosal delivery of y2 receptor-binding peptides and methods for treating and preventing obesity |
US7186692B2 (en) | 2002-12-17 | 2007-03-06 | Nastech Pharmaceutical Company Inc. | Compositions and methods for enhanced mucosal delivery and non-infused administration of Y2 receptor-binding peptides and methods for treating and preventing obesity |
US7229966B2 (en) | 2002-12-17 | 2007-06-12 | Nastech Pharmaceutical Company Inc. | Compositions and methods for enhanced mucosal delivery of Y2 receptor-binding peptides and methods for treating and preventing obesity |
US7166575B2 (en) | 2002-12-17 | 2007-01-23 | Nastech Pharmaceutical Company Inc. | Compositions and methods for enhanced mucosal delivery of peptide YY and methods for treating and preventing obesity |
US7772188B2 (en) | 2003-01-28 | 2010-08-10 | Ironwood Pharmaceuticals, Inc. | Methods and compositions for the treatment of gastrointestinal disorders |
US7741431B2 (en) * | 2005-02-01 | 2010-06-22 | The United States Of America As Represented By The Secretary Of The Army | Liposomes containing novel targeting and/or fusogenic peptides, preparations containing them and therapeutic use thereof |
US20090220587A1 (en) * | 2005-02-01 | 2009-09-03 | United State Army | Liposomal drug delivery constructs targeted by lipid-conjugated peptide ligands |
WO2007041052A2 (en) | 2005-09-29 | 2007-04-12 | Merck & Co., Inc. | Acylated spiropiperidine derivatives as melanocortin-4 receptor modulators |
WO2008039327A2 (en) | 2006-09-22 | 2008-04-03 | Merck & Co., Inc. | Method of treatment using fatty acid synthesis inhibitors |
CA2677045C (en) | 2007-01-31 | 2016-10-18 | Dana-Farber Cancer Institute, Inc. | Stabilized p53 peptides and uses thereof |
KR101623985B1 (ko) | 2007-03-28 | 2016-05-25 | 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 | 스티칭된 폴리펩티드 |
US8106086B2 (en) | 2007-04-02 | 2012-01-31 | Msd K.K. | Indoledione derivative |
EP2310029B1 (en) | 2008-06-12 | 2019-04-03 | Ipsen Bioinnovation Limited | Fusion proteins for use in the treatment of cancer |
BRPI0915888E2 (pt) | 2008-06-12 | 2020-09-01 | Syntaxin Ltd | polipetídeo, seu método de ativação, sequência de ácido nucléico codificando o mesmo e seu uso |
GB0820970D0 (en) | 2008-11-17 | 2008-12-24 | Syntaxin Ltd | Suppression of cancer |
WO2010107486A2 (en) * | 2009-03-18 | 2010-09-23 | The Board Of Trustees Of The Leland Stanford Junior University | Use of somatostatin or an analogue thereof in combination with external radiation therapy |
JP5718925B2 (ja) | 2009-09-28 | 2015-05-13 | インターシア セラピューティクス,インコーポレイティド | 実質的な定常状態薬物送達の迅速な確立及び/又は停止 |
JP5892940B2 (ja) | 2009-11-25 | 2016-03-23 | アリスジェン ソシエテ アノニム | クラウン化合物及び/又は対イオンと複合体化されたペプチドを含む粘膜送達組成物 |
EP3378468A1 (en) | 2010-01-13 | 2018-09-26 | Ipsen Pharma S.A.S. | Process for the preparation of pharmaceutical compositions for the sustained release of somatostatin analogs |
CN102260352B (zh) * | 2010-05-28 | 2013-11-20 | 山东先声麦得津生物制药有限公司 | 靶向性白细胞介素融合蛋白及其制备方法与应用 |
EP2399931A1 (fr) * | 2010-06-22 | 2011-12-28 | Ipsen Pharma S.A.S. | Nouveaux composés octapeptidiques et leur utilisation thérapeutique |
CA2807685C (en) | 2010-08-13 | 2020-10-06 | Aileron Therapeutics, Inc. | P53 derived peptidomimetic macrocycle |
JP6342808B2 (ja) | 2011-10-18 | 2018-06-13 | エイルロン セラピューティクス,インコーポレイテッド | ペプチドミメティック大環状化合物 |
CN107216380A (zh) | 2012-02-15 | 2017-09-29 | 爱勒让治疗公司 | 拟肽大环化合物 |
AU2013221433B2 (en) | 2012-02-15 | 2018-01-18 | Aileron Therapeutics, Inc. | Triazole-crosslinked and thioether-crosslinked peptidomimetic macrocycles |
CA2887285A1 (en) | 2012-11-01 | 2014-05-08 | Aileron Therapeutics, Inc. | Disubstituted amino acids and methods of preparation and use thereof |
CN112245565A (zh) | 2014-09-24 | 2021-01-22 | 艾瑞朗医疗公司 | 拟肽大环化合物及其用途 |
MX2017011834A (es) | 2015-03-20 | 2018-04-11 | Aileron Therapeutics Inc | Macrociclos peptidomimeticos y usos de los mismos. |
WO2017200943A1 (en) | 2016-05-16 | 2017-11-23 | Intarcia Therapeutics, Inc. | Glucagon-receptor selective polypeptides and methods of use thereof |
CN108659100A (zh) * | 2017-03-28 | 2018-10-16 | 上海新生源医药集团有限公司 | 具有镇痛作用的多肽及其应用 |
AR116632A1 (es) | 2018-10-11 | 2021-05-26 | Intarcia Therapeutics Inc | Polipéptidos análogos de la amilina humana y sus métodos de uso |
KR20220017695A (ko) * | 2020-08-05 | 2022-02-14 | 주식회사 레미바이오 | 아스코르브산 유도체 및 이를 포함하는 조성물 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1246055A (en) * | 1980-03-24 | 1988-12-06 | Joseph H. Cort | N-.omega.-substituted hormonogens of vasopressin and its synthetic analogs |
DE3522638A1 (de) * | 1985-06-25 | 1987-01-08 | Diamalt Ag | Neue somatostatin-derivate |
DE3614833A1 (de) | 1986-01-16 | 1987-07-23 | Hoechst Ag | Peptide mit vasorelaxierender, natriuretischer und diuretischer wirkung, verfahren zu ihrer herstellung, diese enthaltende mittel und ihre verwendung |
HU906341D0 (en) * | 1986-10-13 | 1991-04-29 | Sandoz Ag | Process for producing peptonic derivatives modified with sugar and pharmaceutical preparatives containing these compounds as active substance |
GB2218102B (en) * | 1988-04-08 | 1992-09-16 | Sandoz Ltd | Calcitonin peptide derivatives |
ZA895838B (en) | 1988-08-18 | 1991-03-27 | Syntex Inc | Pharmaceutical compounds |
FR2638968B1 (fr) | 1988-11-11 | 1994-10-07 | Sandoz Sa | Nouvelle utilisation therapeutique de la somatostatine et de ses analogues et derives |
WO1991009837A1 (en) * | 1989-12-22 | 1991-07-11 | Commonwealth Scientific And Industrial Research Organisation | Amino acids, peptides or derivatives thereof coupled to fats |
GB9209032D0 (en) * | 1992-04-25 | 1992-06-10 | Ciba Geigy Ag | New peptide derivatives |
-
1994
- 1994-08-08 RO RO96-00225A patent/RO117259B1/ro unknown
- 1994-08-08 EP EP02026862A patent/EP1288223B1/en not_active Expired - Lifetime
- 1994-08-08 AT AT02026862T patent/ATE284413T1/de not_active IP Right Cessation
- 1994-08-08 SG SG1996005779A patent/SG75092A1/en unknown
- 1994-08-08 SK SK150-96A patent/SK15096A3/sk unknown
- 1994-08-08 HU HU9600281A patent/HU224350B1/hu not_active IP Right Cessation
- 1994-08-08 CN CN94193717A patent/CN1055700C/zh not_active Expired - Fee Related
- 1994-08-08 AT AT94924590T patent/ATE241643T1/de not_active IP Right Cessation
- 1994-08-08 JP JP50654195A patent/JP3618750B2/ja not_active Expired - Lifetime
- 1994-08-08 GE GEAP19943038A patent/GEP20002146B/en unknown
- 1994-08-08 ES ES02026863T patent/ES2309131T3/es not_active Expired - Lifetime
- 1994-08-08 SI SI9420051A patent/SI9420051A/sl unknown
- 1994-08-08 SI SI9430451T patent/SI0788509T1/xx unknown
- 1994-08-08 DE DE69432758T patent/DE69432758T2/de not_active Expired - Lifetime
- 1994-08-08 RU RU96104340A patent/RU2133252C1/ru not_active IP Right Cessation
- 1994-08-08 PT PT02026862T patent/PT1288223E/pt unknown
- 1994-08-08 DE DE69435105T patent/DE69435105D1/de not_active Expired - Lifetime
- 1994-08-08 KR KR1019960700664A patent/KR100325972B1/ko not_active IP Right Cessation
- 1994-08-08 WO PCT/US1994/008875 patent/WO1995004752A1/en active IP Right Grant
- 1994-08-08 ES ES02026862T patent/ES2229045T3/es not_active Expired - Lifetime
- 1994-08-08 AU AU74819/94A patent/AU689490B2/en not_active Ceased
- 1994-08-08 NZ NZ271238A patent/NZ271238A/en not_active IP Right Cessation
- 1994-08-08 PT PT94924590T patent/PT788509E/pt unknown
- 1994-08-08 MD MD96-0137A patent/MD1591B2/ro unknown
- 1994-08-08 UA UA96020456A patent/UA44707C2/uk unknown
- 1994-08-08 DE DE69434181T patent/DE69434181T2/de not_active Expired - Lifetime
- 1994-08-08 CZ CZ1996390A patent/CZ292586B6/cs not_active IP Right Cessation
- 1994-08-08 ES ES94924590T patent/ES2196031T3/es not_active Expired - Lifetime
- 1994-08-08 DK DK02026862T patent/DK1288223T3/da active
- 1994-08-08 EP EP94924590A patent/EP0788509B1/en not_active Expired - Lifetime
- 1994-08-08 DK DK94924590T patent/DK0788509T3/da active
- 1994-08-08 CA CA002168113A patent/CA2168113C/en not_active Expired - Fee Related
- 1994-08-08 EP EP02026863A patent/EP1288224B1/en not_active Expired - Lifetime
- 1994-08-08 PL PL94312989A patent/PL180612B1/pl not_active IP Right Cessation
- 1994-08-08 AT AT02026863T patent/ATE399177T1/de not_active IP Right Cessation
- 1994-08-08 DK DK02026863T patent/DK1288224T3/da active
- 1994-08-09 ZA ZA945966A patent/ZA945966B/xx unknown
- 1994-08-09 US US08/287,957 patent/US5552520A/en not_active Expired - Lifetime
-
1996
- 1996-02-08 FI FI960584A patent/FI960584A0/fi not_active Application Discontinuation
- 1996-03-06 LT LT96-025A patent/LT4078B/lt not_active IP Right Cessation
- 1996-03-08 LV LVP-96-71A patent/LV11549B/en unknown
-
2000
- 2000-03-22 CZ CZ20001033A patent/CZ289552B6/cs not_active IP Right Cessation
- 2000-03-22 CZ CZ20001032A patent/CZ289590B6/cs not_active IP Right Cessation
-
2003
- 2003-08-04 HK HK03105591A patent/HK1053313A1/xx not_active IP Right Cessation
- 2003-08-04 HK HK03105592A patent/HK1053314A1/xx not_active IP Right Cessation
-
2004
- 2004-08-12 JP JP2004235503A patent/JP3869439B2/ja not_active Expired - Lifetime
- 2004-08-12 JP JP2004235535A patent/JP3785179B2/ja not_active Expired - Lifetime
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1053313A1 (en) | Therapeutic peptide derivatives. | |
GB8922026D0 (en) | Novel anti-viral and cytotoxic agent | |
AU5162796A (en) | Novel peptide derivatives | |
ES2172069T3 (es) | Derivado tetrapeptidico. | |
UA32523C2 (uk) | Пептиди, які мають високу біологічну активність, та фармацевтична композиція на їх основі | |
AU4218389A (en) | Peptide compounds | |
AU3428089A (en) | Therapeutic peptides | |
RU95119704A (ru) | Иммуностимулятор и препарат на его основе | |
GB9604518D0 (en) | Novel compounds | |
ATE69240T1 (de) | Mitogene peptide. | |
MX9909548A (es) | Metodos para la reduccion de fibrinogenos. | |
MX9603809A (es) | Preparado combinado farmaceutico con ketoprofeno. |